Theralase(R) Launches New Clinical Study Site in Canada
St. Joseph's Healthcare Hamilton is the latest Canadian clinical study site for clinical investigation of Theralase®'s Anti-Cancer Therapy for the...
Cancer
Prenetics’ IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services
Mission Launched via SpaceX CRS-31; Experiment Now Underway on the ISSCollaboration Aims to Enhance Healthspan on Earth and Improve Astronaut...
Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025
First-in-class catheter-based sensing technology designed to sense neuronal signals that indicate pain or disease and destroy those nerves at the...
Theriva™ Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of VCN-01 for the Treatment of Metastatic Pancreatic Cancer
ROCKVILLE, Md., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed...
TScan Therapeutics Named a Top Place to Work by The Boston Globe for Three Consecutive Years
WALTHAM, Mass., Dec. 05, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the...
RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery System
Over Ten Medical Institutions Nationwide have Initiated RenovoCath Purchase Process, Further Accelerating Commercialization Strategy RenovoRx Estimates Initial Target Market Size...
Medicenna Provides Clinical Update and Announces First Complete Responder in MDNA11 and KEYTRUDA® (pembrolizumab) Combination Dose Escalation Arm of the ABILITY-1 Study
70-year-old patient with advanced chemo-refractory anal cancer achieves complete response (CR) in 8 weeks when treated with MDNA11 in combination...
Outcomes4Me and CURE® Media Group Partner to Accelerate Patient Access to Innovative Cancer Therapies
Exclusive collaboration empowers patients with cancer through access to evidence-based and informative resources that provide guidance at every stage of...
Up to $1.6 Million in Funding Available for NSF Tissue Engineering Research Utilizing the ISS National Lab
Solicitation now open for multiple awards supporting space-based tissue engineering and mechanobiology research KENNEDY SPACE CENTER, Fla., Dec. 4, 2024...
New Study Indicates SpotitEarly Detects Multiple Cancers Early By Using AI, Trained Canines And Breath Samples
Innovative platform can identify breast, lung, prostate and colorectal cancers with a single, non-invasive test ENGLEWOOD, N.J., Dec. 4, 2024...
Cleerly Raises $106 Million in Funding Led by Insight Partners to Revolutionize Heart Disease Care
DENVER, Dec. 4, 2024 /PRNewswire/ -- Today Cleerly, a leader in advanced cardiovascular imaging, announced the successful closure of its Series...
Study published in the New England Journal of Medicine AI Concludes that the Sepsis ImmunoScore™, the First FDA-Authorized AI Tool for Sepsis, has both significant Diagnostic and Predictive Power
Groundbreaking NEJM AI Study Highlights the Ability of Prenosis' Sepsis ImmunoScore™ to Holistically Predict Adverse Outcomes, Ushering in a New...
BioFuse Medical Technologies Announces New CEO and Strategic Appointments to Advisory Team
TAMPA, FL / ACCESSWIRE / December 4, 2024 / BioFuse Medical Technologies proudly announces the appointment of Rick Earley as...
Bispecific Antibody, APVO442, Differentiated to Treat Prostate Cancer with Precision Tumor Targeting and Reduced Risk of Side Effects
Powered by Aptevo's proprietary ADAPTIR-FLEX®platform, antibody innovation targeting difficult-to-treat cancers SEATTLE, WA / ACCESSWIRE / December 4, 2024 / Aptevo...
Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in a Mobile Configuration
Full-service medical oncology practice to pioneer the use of SRT to treat companion animals for both home and veterinary clinic...
Adaptive Research Welcomes Western Radiation Oncology to Expand Community Access to Pioneering Cancer Treatment Trials
SAN FRANCISCO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Adaptive Research and Western Radiation Oncology (WRO) have announced that WRO has...
New Technology from Riverain Adds Coronary Artery Calcification Scoring to Ungated Chest CT Scans
Incidental CAC Scores Now Possible with ClearRead™ CT MIAMISBURG, Ohio, Dec. 3, 2024 /PRNewswire/ -- Coronary artery calcification (CAC) affects...
In-Vitro and In-Vivo Micro Electrode Array Market to Grow by USD 7 Million (2024-2028), Driven by MEA Applications in Neuroscience Research, with AI Driving Market Transformation – Technavio
NEW YORK, Dec. 3, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global in-vitro and...
Hollywood Futurist Ted Schilowitz Joins Novobeing as Strategic Investor and Executive Team Member
BOSTON, Dec. 3, 2024 /PRNewswire/ -- Novobeing,a leader in medical virtual reality for enhanced patient care, is proud to welcome...
Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries
The Acquisition of NexGenAI Affiliates Network Expands Company's Capabilities and Drives Innovation, Operational Efficiency, and Opportunity for Growth WEXFORD, Pa. ,...